Neutron capture therapy device and collimator

By configuring a speed reduction member and a gamma ray shielding member in the collimator of the neutron capture treatment device, the transmission path of neutron rays is shortened, the problem of insufficient neutron ray intensity and flux is solved, and the neutron capture treatment device is realized efficient treatment.

CN119095648APending Publication Date: 2024-12-06SUMITOMO HEAVY IND LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380031295.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-29
Filing Date
2023-03-28
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

In the existing neutron capture treatment device, the intensity and flux of the neutron rays are insufficient, resulting in a long treatment time and the inability to effectively increase the neutron flux to the irradiated object.

Method used

A neutron capture treatment device is designed, by configuring a reduction member in the hole of the collimator to bring the target closer to the irradiated object, and adjusting the position of the reduction member using the protrusion and gamma ray shielding member to shorten the neutron rays. the transmission pathway, thereby improving neutron flux and shortening treatment time.

Benefits of technology

The neutron flux to the irradiated object is achieved and the treatment time is shortened, and the neutron flux is increased by about 10%, so the device is miniaturized.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119095648A_ABST
    Figure CN119095648A_ABST
Patent Text Reader

Abstract

The neutron capture therapy device comprises: an accelerator for generating a particle beam; a target that generates neutron rays by reacting with the particle beams; a collimator having a hole portion penetrating in the irradiation direction of the neutron rays and forming a radiation field of the neutron rays generated from the target; and a decelerating member that decelerates the neutron rays generated from the target, and a part of the decelerating member is disposed inside the hole of the collimator.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to a neutron capture therapy device and a collimator. Background Art

[0002] As a neutron capture therapy that kills cancer cells by irradiating neutron beams, boron neutron capture therapy (BNCT) using boron compounds is known. In BNCT, boron pre-doped into cancer cells is irradiated with neutron beams, and the resulting scattering of heavy charged particles selectively destroys the cancer cells.

[0003] The neutron capture therapy apparatus disclosed in Patent Document 1 decelerates neutrons generated in a target using a deceleration member, forms a radiation field using a collimator, and irradiates the neutrons to the irradiated object. Thus, the deceleration member can decelerate the neutrons to an appropriate energy.

[0004] Previous technical literature

[0005] Patent Literature

[0006] Patent Document 1: Japanese Patent Application Publication No. 2020-146119 Summary of the invention

[0007] Technical issues to be solved by the invention

[0008] Here, in order to reduce the burden on the irradiated body, it is expected to increase the intensity of neutron beams and shorten the treatment time. However, due to limitations such as the heat resistance of the accelerator and the target, the intensity of the particle beam that can irradiate the target and the intensity of the neutron beam generated in the target are limited. Therefore, it is expected to increase the neutron flux irradiated to the irradiated body by methods other than increasing the intensity of the neutron beam generated in the target.

[0009] Therefore, an object of the present disclosure is to provide a neutron capture therapy apparatus and a collimator that can increase the neutron flux irradiated to an irradiated body and shorten the treatment time.

[0010] Means for solving technical problems

[0011] The neutron capture therapy device disclosed herein comprises: an accelerator for generating a particle beam; a target for generating neutron rays by reacting with the particle beam; a collimator having a hole penetrating along the irradiation direction of the neutron rays and forming a radiation field of the neutron rays generated from the target; and a deceleration member for decelerating the neutron rays generated from the target, a part of the deceleration member being arranged inside the hole of the collimator.

[0012] The neutron capture therapy device disclosed in the present invention has a collimator having a hole portion penetrating along the irradiation direction of the neutron beam, and forming a radiation field of the neutron beam generated from the target. Therefore, the neutron beam passes through the hole portion of the collimator and irradiates the irradiated body in the radiation field corresponding to the shape of the collimator. In addition, the neutron beam is irradiated to the irradiated body in a state of appropriate energy adjusted by a deceleration component at a predetermined distance from the target. Here, a part of the deceleration component is arranged inside the hole portion of the collimator. Therefore, by arranging the deceleration component inside the hole portion of the collimator, the target can be arranged closer to the irradiated body. The closer the distance between the target and the irradiated body, the greater the neutron flux. As a result, the neutron flux irradiated to the irradiated body can be increased and the treatment time can be shortened.

[0013] At least a part of the collimator is detachable. In this case, by replacing the collimator, the size of the deceleration member arranged inside the collimator can be easily adjusted.

[0014] The collimator may have a protrusion protruding from the wall surface, and a deceleration member may be provided in the hole of the protrusion. In this case, the deceleration member may be arranged at a position closer to the irradiated object than the wall surface, thereby shortening the distance between the target and the irradiated object.

[0015] At least a portion of the protrusion can be removed from the wall surface. Thus, a portion of the collimator can be easily removed from the wall surface. That is, the size of the deceleration member arranged in the hole portion of the collimator can be easily adjusted.

[0016] In the hole of the protrusion, the deceleration member can be arranged in a range of more than half of the protrusion in the irradiation direction. Thus, the deceleration member arranged in the hole of the protrusion can be increased, and thus the distance between the target and the irradiated object can be shortened accordingly.

[0017] The wall surface may extend in a direction perpendicular to the irradiation direction. In this case, the protrusion is configured to protrude in the irradiation direction, and the structure is simple.

[0018] A gamma ray shielding member may be arranged on the irradiated object side of the hole portion of the collimator. The gamma ray shielding member is arranged on the downstream side of the irradiation direction relative to the deceleration member. Therefore, by arranging the gamma ray shielding member on the irradiated object side of the hole portion, sufficient space can be ensured in the hole portion to arrange the deceleration member.

[0019] The collimator according to the present disclosure forms a radiation field of neutron beams. The collimator has a hole portion penetrating along the irradiation direction of the neutron beams, and a deceleration member for decelerating neutrons is arranged inside the hole portion.

[0020] According to the collimator involved in the present disclosure, it is possible to obtain the same effects as those of the above-mentioned neutron capture therapy apparatus.

[0021] Effects of the Invention

[0022] The present disclosure can provide a neutron capture therapy device and a collimator that can increase the neutron flux irradiated to an irradiated body and shorten the treatment time. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 It is a schematic diagram showing a neutron capture therapy apparatus according to an embodiment of the present disclosure.

[0024] Figure 2 This is a schematic diagram of a neutron generating unit.

[0025] Figure 3 This is a schematic diagram of a neutron generating unit according to a comparative example.

[0026] Figure 4 It is a cross-sectional view showing a collimator according to a modified example.

[0027] Figure 5 It is a cross-sectional view showing a collimator according to a modified example. DETAILED DESCRIPTION

[0028] Hereinafter, preferred embodiments of the present disclosure will be described in detail with reference to the accompanying drawings.

[0029] First, refer to Figure 1 , an overview of the neutron capture therapy apparatus according to an embodiment of the present disclosure is described. Figure 1 The neutron capture therapy device 1 shown is a device for treating cancer using boron neutron capture therapy (BNCT). In the neutron capture therapy device 1, for example, a boron-injected neutron on a treatment table 51 is injected with 10 B) The tumor of patient 50 was irradiated with neutron beam N.

[0030] The neutron capture therapy device 1 includes an accelerator 2. The accelerator 2 accelerates charged particles such as negative ions and emits a charged particle beam R. The accelerator 2 is composed of, for example, a cyclotron. In the present embodiment, the charged particle beam R is a proton beam generated by stripping charges from negative ions. The accelerator 2 generates, for example, a charged particle beam R with a beam radius of 40 mm and 60 kW (=30 MeV×2 mA). In addition, the accelerator is not limited to a cyclotron, and may also be a synchrotron or a synchrocyclotron, a linear accelerator, an electrostatic accelerator, or the like.

[0031] The charged particle beam R emitted from the accelerator 2 is sent to the neutron beam generating unit M. The neutron beam generating unit M is composed of a beam guide 9 (transmission path) and a target 10. The charged particle beam R emitted from the accelerator 2 passes through the beam guide 9 and travels toward the target 10 arranged at the end of the beam guide 9. A plurality of quadrupole electromagnets 4 and scanning electromagnets 6 are provided along the beam guide 9. The plurality of quadrupole electromagnets 4 adjust the beam diameter of the charged particle beam R using, for example, electromagnets.

[0032] The scanning electromagnet 6 scans the charged particle beam R and controls irradiation of the target 10 with the charged particle beam R. The scanning electromagnet 6 controls the irradiation position of the charged particle beam R with respect to the target 10 .

[0033] The neutron capture therapy apparatus 1 includes a neutron generator 100 that generates neutron beams N by irradiating a target 10 with a charged particle beam R, and emits the neutron beams N toward a patient 50 . The neutron generator 100 includes a target 10 , a shield 8 , a deceleration member 39 , and a collimator 20 .

[0034] The target 10 generates neutron beams N under the irradiation of the charged particle beam R. The target 10 is a solid-shaped component formed of a material that generates neutron beams by irradiation with the charged particle beam. Specifically, the target 10 is formed of, for example, beryllium (Be), lithium (Li), tantalum (Ta), and tungsten (W), and has a disk-shaped solid shape with a diameter of 160 mm. In addition, the target 10 is not limited to a disk shape, and may also be other shapes.

[0035] The deceleration member 39 decelerates the neutron beam N generated in the target 10 (reduces the energy of the neutron beam N). The deceleration member 39 may have a laminated structure formed by a layer 39A that mainly decelerates fast neutrons included in the neutron beam N and a layer 39B that mainly decelerates epithermal neutrons included in the neutron beam N. As a material for the deceleration member 39, a material having a large total cross-sectional area for neutrons of 40 keV or more is used. Specifically, as a material for the deceleration member 39, CaF2, MgF2, AlF3, D2O, polyethylene, etc. can be cited.

[0036] The shielding body 8 shields the generated neutron beam N and the gamma rays generated along with the generation of the neutron beam N, so as to prevent them from being released to the outside. The shielding body 8 is arranged to surround the deceleration member 39. The upper and lower parts of the shielding body 8 extend from the deceleration member 39 to the upstream side of the charged particle beam R. As the material of the neutron shielding member of the shielding body 8, a material with a large total cross-sectional area for neutrons below 0.5 eV is used. Examples of materials for the neutron shielding member include Li, boron, cadmium, polyethylene, etc. As the material of the gamma-ray shielding member of the shielding body 8, a material with a large total cross-sectional area for gamma rays is used. Examples of materials for the gamma-ray shielding member include lead, iron, etc.

[0037] The collimator 20 shapes the radiation field of the neutron beam N and has an opening 20 a through which the neutron beam N passes. The collimator 20 is, for example, a block-shaped member having a hole 21 at the center.

[0038] Next, refer to Figure 2 , the structure of the neutron generating unit 100 is described. In the following description, the irradiation axis of the charged particle beam R is sometimes referred to as the reference line CL. The reference line CL is the center position of the irradiation of the neutron beam N. In the following description, the "irradiation direction D1" refers to the irradiation direction of the charged particle beam R and the neutron beam N. Figure 2 As shown, the shield 8 includes a main body 11 , an outer layer 12 , and a wall 13 .

[0039] The main body 11 is arranged to surround the reference line CL. The main body 11 has holes 11a and 11b extending along the reference line CL. The hole 11a is arranged on the upstream side of the irradiation direction D1, and the hole 11b is arranged on the downstream side. The hole 11a is an internal space for guiding the charged particle beam R toward the target 10. The hole 11b is an internal space for arranging the deceleration member 39. The outer layer 12 is arranged on the outer periphery of the main body 11 in a direction orthogonal to the reference line CL.

[0040] The wall portion 13 is disposed at the end portion on the downstream side of the main body portion 11 in the irradiation direction D1. The wall portion 13 extends perpendicularly to the reference line CL. The wall portion 13 is used as a space between the accelerator chamber 101 (reference Figure 1 ) and equipped with a treatment table 51 (reference Figure 1 ) serves as a partition separating the treatment room 102 from the treatment room 102. In the treatment room 102, the wall surface 13a on the downstream side of the irradiation direction D1 of the wall portion 13 extends perpendicularly to the irradiation direction D1. In the accelerator room 101, the wall surface 13b on the upstream side of the irradiation direction D1 of the wall portion 13 extends perpendicularly to the irradiation direction D1. In addition, the lower end of the wall portion 13 is connected to the floor, and the upper end is connected to the ceiling. The floor and the ceiling also serve as a shielding body for shielding radiation.

[0041] The collimator 20 is formed at the position of the reference line CL of the wall portion 13. The collimator 20 is configured by forming a hole portion 21 penetrating along the irradiation direction D1 in the wall portion 13. The hole portion 21 has inner peripheral surfaces 21a, 21b, and 21c in sequence from the upstream side to the downstream side of the irradiation direction D1. The inner peripheral surface 21a is a cylindrical surface having an inner diameter that is the same as the inner diameter of the hole portion 11b of the main body 11. The inner peripheral surface 21b is an inclined surface having a cross-sectional shape in which the inner diameter decreases toward the downstream side of the irradiation direction D1. The inner peripheral surface 21c is a cylindrical surface having an inner diameter smaller than that of the inner peripheral surface 21a.

[0042] With this structure, the collimator 20 has an aperture portion (a diaphragm portion) 22 protruding from the inner peripheral surface 21a toward the inner peripheral side. The aperture portion 22 reduces the range of the radiation field of the neutron beam N. At the location of the boundary line BL, the aperture portion 22 can be constructed as a component separate from the wall portion 13. In this case, the aperture portion 22 as a separate component is embedded in the inner peripheral surface 21a of the wall portion 13. The aperture portion 22 can be detachable relative to the wall portion 13, or it can be fixed to be non-detachable. Alternatively, the aperture portion 22 can be formed integrally with other parts of the wall portion 13. In this case, at the location of the boundary line BL, the material of the wall portion 13 is continuous without interruption.

[0043] The layers 39A and 39B of the deceleration member 39 are provided in the hole 11b of the main body 11. The target 10 is arranged in the hole 11a of the main body 11.

[0044] The deceleration member 39 has a layer 39C disposed inside the hole 21 of the collimator 20 in addition to the above-mentioned layers 39A and 39B. The layer 39C is disposed at a portion corresponding to the inner peripheral surface 21a and the inner peripheral surface 21b of the collimator 20. The outer peripheral surface of the layer 39C is disposed so as to contact the inner peripheral surfaces 21a and 21b of the hole 21. With this structure, a part of the deceleration member 39 is disposed inside the hole 21 of the collimator 20.

[0045] A gamma-ray shielding member 26 is disposed on the patient 50 side of the aperture 21 of the collimator 20. Specifically, a gamma-ray shielding member 26 for shielding gamma-rays is provided at a portion corresponding to the inner peripheral surface 21c in the interior of the aperture 21. In addition, when the aperture portion 22 is detachable relative to the wall portion 13, the portion of the layer 39C corresponding to the inner peripheral surface 21b and the gamma-ray shielding member 26 can be detachable together with the aperture portion 22.

[0046] Next, the effects of the neutron capture therapy apparatus 1 and the collimator 20 according to the present embodiment will be described.

[0047] The neutron capture therapy apparatus 1 according to the present embodiment includes a collimator 20 having a hole 21 penetrating in the irradiation direction D1 of the neutron beam N, and forming a radiation field of the neutron beam N generated from the target 10. Therefore, the neutron beam N passes through the hole 21 of the collimator 20 and is irradiated to the patient 50 in the radiation field corresponding to the shape of the collimator 20. Furthermore, the neutron beam N is irradiated to the patient 50 in a state adjusted to an appropriate energy by the deceleration member 39 at a predetermined distance from the target 10.

[0048] Here, reference Figure 3 , the neutron capture therapy device involved in the comparative example is described. Figure 3 As shown, the neutron capture therapy apparatus according to the comparative example does not include the deceleration member 39 inside the hole 21 of the collimator 20. The gamma-ray shielding member is arranged on the inner peripheral surface 21a at the most upstream side in the irradiation direction D1 of the collimator 20. The dimension between the target 10 and the wall surface 13a in the irradiation direction D1 is defined as L3.

[0049] In contrast, in the neutron capture therapy apparatus 1 according to the present embodiment, a portion of the deceleration member 39 is disposed inside the hole 21 of the collimator 20. Therefore, by disposing the deceleration member 39 inside the hole 21 of the collimator 20, the target 10 can be brought closer to the patient 50. For example, Figure 2 In the embodiment, the layer 39C of the deceleration member 39 disposed inside the hole 21 of the collimator 20 has a dimension L2. Therefore, the dimension L1 between the target 10 and the wall surface 13a in the irradiation direction D1 is shorter by L2 than the dimension L3 of the comparative example. That is, in the present embodiment, the target 10 can be disposed closer to the patient 50 by a dimension L2 than the comparative example. The closer the distance between the target 10 and the patient 50, the higher the neutron flux. For example, for Figure 2 The embodiments shown involve models and Figure 3 The model of the comparative example shown in the figure was calculated, and as a result, it was confirmed that in the model of the embodiment, the neutron flux can be increased by about 10% compared with the model of the comparative example, when the conditions other than the deceleration member 39 are the same. As a result, the neutron flux irradiated to the patient 50 can be increased and the treatment time can be shortened. In addition, by shortening the distance between the target 10 and the patient 50, the neutron capture therapy device 1 can be miniaturized.

[0050] At least a part of the collimator 20 is detachable. In this case, by replacing the collimator 20, the size of the deceleration member 39 disposed inside the collimator 20 can be easily adjusted.

[0051] The gamma-ray shielding member 26 may be disposed on the patient 50 side of the hole 21 of the collimator 20. The gamma-ray shielding member 26 is disposed on the downstream side of the deceleration member 39 in the irradiation direction D1. Therefore, by disposing the gamma-ray shielding member 26 on the patient 50 side of the hole 21, a space in which the deceleration member 39 can be disposed can be ensured in the hole 21.

[0052] The collimator 20 according to the present embodiment forms a radiation field of the neutron beam N. The collimator 20 has a hole 21 penetrating in the irradiation direction D1 of the neutron beam N. A deceleration member 39 for decelerating the neutron beam N is disposed inside the hole 21 .

[0053] According to the collimator 20 according to the present invention, the same effects as those of the above-mentioned neutron capture therapy apparatus 1 can be obtained.

[0054] The present invention is not limited to the above-mentioned embodiments.

[0055] For example, the structure of the neutron capture therapy device 1 described above is only an example and can be modified appropriately.

[0056] The structure of the collimator 20 is not limited to the above-mentioned embodiment. Figure 4 The collimator 20 shown. Figure 4 As shown in (a), the collimator 20 includes an inner peripheral surface 21a of the wall portion 13 and a protrusion 40. The protrusion 40 protrudes from the wall surface 13a of the wall portion 13. The protrusion 40 has a cylindrical structure of a truncated cone. The protrusion 40 has an end 40c on the upstream side and an end 40d on the downstream side in the irradiation direction D1. The end 40c on the upstream side is installed in a state of contact with the wall surface 13a of the wall portion 13. The diameter of the inner peripheral surface 40a is the same as the diameter of the inner peripheral surface 21a of the wall portion 13. The diameters of the inner peripheral surface 40a and the outer peripheral surface 40b decrease as they move from the end 40c toward the end 40d.

[0057] A gamma-ray shielding member 26 is disposed on the patient 50 side of the hole 21 of the protrusion 40. The gamma-ray shielding member 26 is disposed at the position of the end 40d on the downstream side of the protrusion 40. A layer 39D of the deceleration member 39 is provided in the hole 21 of the protrusion 40. The layer 39D of the deceleration member 39 extends from the position of the end 40c on the upstream side of the protrusion 40 to the position of the gamma-ray shielding member 26. In the hole 21 of the protrusion 40, the deceleration member 39 is disposed over a range of more than half of the protrusion 40 in the irradiation direction D1.

[0058] The protrusion 40 can be removed from the wall surface 13a. The end portion 40c of the protrusion 40 on the downstream side of the irradiation direction D1 can be removed from the wall surface 13a of the wall portion 13. Figure 4As shown in FIG. 2( b ), the layer 39D of the deceleration member 39 and the gamma-ray shielding member 26 inside the hole 21 of the protrusion 40 can also be removed from the wall portion 13 together with the protrusion 40 .

[0059] The protrusion 40 with respect to the wall portion 13 can be replaced according to the amount of the deceleration member 39 required. Figure 4 The protrusion 40 shown is changed to Figure 5 The protrusion 40 shown in (a) or Figure 5 The protrusion 40 shown in (b). Figure 5 The protrusion 40 shown in (a) has a Figure 4 The deceleration member 39 of the protrusion 40 shown in (b) is thinner than the layer 39D of the deceleration member 39. The layer 39E is arranged at a position closer to the downstream side of the irradiation direction D1 than the end 40c of the protrusion 40. In this way, the deceleration member 39 can be arranged in the hole 21 of the protrusion 40 within a range of more than one third of the protrusion 40 in the irradiation direction D1. Figure 5 The protrusion 40 shown in (b) does not have the decelerating member 39 .

[0060] As described above, the collimator 20 may include the protrusion 40 protruding from the wall surface 13a, and the deceleration member 39 may be provided in the hole 21 of the protrusion 40. In this case, the deceleration member 39 may be arranged at a position closer to the patient 50 than the wall surface 13a, thereby shortening the distance between the target 10 and the patient 50.

[0061] At least a portion of the protrusion 40 is detachable from the wall surface 13a. Thus, a portion of the collimator 20 can be easily detached from the wall surface 13a. That is, the size of the deceleration member 39 disposed in the hole 21 of the collimator 20 can be easily adjusted.

[0062] In the hole 21 of the protrusion 40, the deceleration member 39 can be arranged in the range of more than half of the protrusion 40 in the irradiation direction D1. Thus, the deceleration member 39 arranged in the hole 21 of the protrusion 40 can be increased, and the distance between the target 10 and the patient 50 can be shortened accordingly.

[0063] The wall surface 13a may extend perpendicularly to the irradiation direction D1. In this case, the protrusion 40 has a simple structure that protrudes in the irradiation direction D1.

[0064] Explanation of symbols

[0065] 1- neutron capture therapy device, 2- accelerator, 9- beam guide tube (transmission path), 10- target, 13a- wall surface, 20- collimator, 21- hole portion, 26- gamma ray shielding member, 39- deceleration member, 40- protrusion.

Claims

1. A neutron capture therapy device, comprising: accelerators, which produce particle beams; a target that generates neutron rays by reacting with the particle beam; a collimator having a hole portion penetrating along an irradiation direction of the neutron ray and forming a radiation field of the neutron ray generated from the target; and a deceleration member for decelerating the neutron rays generated from the target, A portion of the deceleration member is disposed inside the hole of the collimator.

2. The neutron capture therapy device according to claim 1, wherein: At least a portion of the collimator is detachable.

3. The neutron capture therapy device according to claim 1, wherein: The collimator has a protruding portion protruding from a wall surface, and the decelerating member is provided in the hole portion of the protruding portion.

4. The neutron capture therapy device according to claim 3, wherein: At least a portion of the protrusion is detachable from the wall surface.

5. The neutron capture therapy device according to claim 3, wherein: The decelerating member is arranged in the hole of the protruding portion over a range of more than half of the protruding portion in the irradiation direction.

6. The neutron capture therapy device according to claim 3, wherein: The wall surface extends perpendicularly to the irradiation direction.

7. The neutron capture therapy device according to claim 1, wherein: A gamma-ray shielding member is disposed on the irradiated object side of the hole portion of the collimator.

8. A collimator that forms a radiation field of neutron rays, The collimator has a hole portion penetrating along the irradiation direction of the neutron beam, A deceleration member for decelerating the neutron beam is arranged inside the hole.